Study of Antidepressants in Parkinson's Disease

• Status: Completed
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to find out if two antidepressant medications, paroxetine and venlafaxine, can help control depression in Parkinson's disease, and if these medications affect the motor symptoms of Parkinson's disease such as tremor, stiffness, slowness, and balance.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Rochester
• Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
• Treatments: Antidepressive Agents; Paroxetine; Venlafaxine Hydrochloride

Criteria

Inclusion Criteria:

To be eligible you must be:

• 30 years old or older

• diagnosed with Parkinson's disease

• experiencing symptoms of depression such as sadness, decreased energy, or problems sleeping